In 2024, Viatris spent some *** million U.S. dollars on research and development. Operating expenses for research and development have steadily decreased until 2020, but increased again for the first time in 2021. This statistic shows the expenses for research and development of pharmaceutical company Viatris from 2016 to 2024. Viatris is a global healthcare company headquartered in the United States with global centers in Pennsylvania, Shanghai and Hyderabad, India. The company was formed in November 2020 through the combination of Mylan and the Upjohn Business (owned by Pfizer Inc.). Its global portfolio comprises more than approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized iconic brands (such as Viagra, Xanax, Lipitor).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Viatris, & U.S. Securities and Exchange Commission. (February 27, 2025). Research and development expenses of Viatris from 2016 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1234915/research-development-expenses-viatris/
Viatris, und U.S. Securities and Exchange Commission. "Research and development expenses of Viatris from 2016 to 2024 (in million U.S. dollars) ." Chart. February 27, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1234915/research-development-expenses-viatris/
Viatris, U.S. Securities and Exchange Commission. (2025). Research and development expenses of Viatris from 2016 to 2024 (in million U.S. dollars) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1234915/research-development-expenses-viatris/
Viatris, and U.S. Securities and Exchange Commission. "Research and Development Expenses of Viatris from 2016 to 2024 (in Million U.S. Dollars) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 27 Feb 2025, /statistics/1234915/research-development-expenses-viatris/
Viatris & U.S. Securities and Exchange Commission, Research and development expenses of Viatris from 2016 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1234915/research-development-expenses-viatris/ (last visited July 24, 2026)
Research and development expenses of Viatris from 2016 to 2024 (in million U.S. dollars) [Graph], Viatris, & U.S. Securities and Exchange Commission, February 27, 2025. [Online]. Available: /statistics/1234915/research-development-expenses-viatris/
